Transcriptional suppression of cytokine-induced iNOS gene expression by IL-13 through IRF-1/ISRE signaling

Biochem Biophys Res Commun. 2007 Oct 26;362(3):582-6. doi: 10.1016/j.bbrc.2007.07.203. Epub 2007 Aug 21.

Abstract

IL-13 has been reported as one of the major down-regulators of iNOS expression in various tissues and cells. The molecular mechanism of iNOS suppression by IL-13 remains unclear, especially at the transcriptional stage. In this study, we found that IL-13 inhibited the expression of iNOS mRNA, protein, and NO product in a concentration-dependent manner for cytokine-stimulated rat hepatocytes. The most effective dose for IL-13 inhibitory effect is approximately 5 ng/ml. IL-13 also decreased the rat iNOS transcriptional activity by promoter analysis, but had no effect on iNOS mRNA stability. By using TranSignal Protein/DNA Combo Array, we identified cytokine-stimulated IRF-1/ISRE binding that was decreased by the addition of IL-13. Gel shift assay confirmed that IL-13 reduced the IRF-1/ISRE binding at nucleotides -913 to -923 of the rat iNOS promoter. Western blot revealed that IL-13 diminished the relative amount of IRF-1 protein translocated to the nucleus. Our data demonstrate that IL-13 down-regulates the cytokine-induced iNOS transcription by decreasing iNOS specific IRF-1/ISRE binding activity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Nucleus / metabolism
  • Cytokines / metabolism
  • Down-Regulation
  • Gene Expression Regulation, Enzymologic*
  • Hepatocytes / metabolism
  • Interferon Regulatory Factor-1 / metabolism*
  • Interleukin-13 / biosynthesis*
  • Interleukin-13 / metabolism
  • Models, Biological
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / biosynthesis*
  • Plasmids / metabolism
  • Rats
  • Signal Transduction*
  • Transcription, Genetic*

Substances

  • Cytokines
  • Interferon Regulatory Factor-1
  • Interleukin-13
  • Nitric Oxide
  • Nitric Oxide Synthase Type II